Q1 2020

Filed Jul 7, 2020 · 10-Q · 98 days after period end · 0001654954-20-007405

Q1 2020 · 10-Q

Revenue

$0.00

−100.0% vs Q1 2019

Net Income

$2.73M

N/M vs Q1 2019

EPS Diluted

$0.04

N/M vs Q1 2019

Gross Profit$0−100.0%

Operating Income

Same quarter

Metric	Q1 2020	Q1 2019	Q1 2018	Q1 2017
Revenue	$0.00	$18.00K	$4.00K	$21.00K
Net Income	$2.73M	-$215.00K	$1.08M	-$107.00K
EPS Diluted	$0.04	-$0.07	$0.00	-$0.22

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR